1. Evans M, Lewis RD, Morgan AR, et al. A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther. 2022;39(1):33-43. doi:10.1007/s12325-021-01927-z
2. https://www.aa.com.tr/tr/saglik/turk-nefroloji-dernegi-bobrek-hastaliklarina-ve-yayginligina-dikkati-cekti/3163411. (Accessed on 24. 09.2024).
3. Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: beyond erythropoietin. Adv Ther. 2021;38(1):52-75. doi: 10.1007/s12325-020-01524-6
4. Pramod S, Goldfarb DS. Challenging patient phenotypes in the management of anaemia of chronic kidney disease. Int J Clin Pract. 2021;75(11):e14681. doi:10.1111/ijcp.14681
5. Van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data. BMC Nephrol. 2020;21(1):88. doi:10.1186/s12882-020-01746-4
6. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 2019;142(1):44-50. doi:10.1159/ 000496492
7. Al-Jabi SW, Rajabi NS, Koni AA, Zyoud SH. A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life. BMC Nephrol. 2023;24(1):197. doi:10. 1186/s12882-023-03254-7
8. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. doi:10.1161/CIR.0000000000000678
9. KDIGO clinical practice guideline for anemia in chronic kidney disease. https://kdigo.org/2023/ on 21.03.2025).
10. Turgeon ML. Cinical Hematology Theory&Procedures. Fifth edition. 2012. Wolters Kluwer, Lippincott Williams&Wilkins. Chapter 10. Iron deficiency Anemia and Anemia of Chronic Inflammation. pp.173-176.
11. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023. doi:10.1056/NEJMra041809
12. Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. 1995; Boston: The Health Institute, New England Medical Center.
13. Soylu C, Bahtım K. Reliability and Validity of the Turkish Version of SF-12 Health Survey. SF-12 Yaşam Kalitesi Ölçeği’nin türkçe formunun güvenirlik ve geçerlilik çalışması. Turk Psikiyatri Derg. 2022;33(2):108-117. doi:10.5080/u25700
14. Doan KVD, Nguyen HTM, Nguyen NTH, Dang KC, Yang SH, Duong TV. Associations of socio-demographic, clinical and biochemical parameters with healthcare cost, health- and renal-related quality of life in hemodialysis patients: a clinical observational study. Int J Environ Res Public Health. 2020;17(18):6552. doi:10.3390/ijerph17186552
15. Mahato SKS, Apidechkul T, Sriwongpan P, et al. Factors associated with quality of life among chronic kidney disease patients in Nepal: a cross-sectional study. Health Qual Life Outcomes. 2020;18(1):207. doi:10.1186/s12955-020-01458-1
16. Chen JY, Wan EYF, Choi EPH, et al. The health-related quality of life of Chinese Patients on hemodialysis and peritoneal dialysis. Patient. 2017; 10(6):799-808. doi:10.1007/s40271-017-0256-6
17. Molsted S, Wendelboe S, Flege MM, Eidemak I. The impact of marital and socioeconomic status on quality of life and physical activity in patients with chronic kidney disease. Int Urol Nephrol. 2021;53(12):2577-2582. doi:10.1007/s11255-021-02826-6
18. Floria I, Kontele I, Grammatikopoulou MG, Sergentanis TN, Vassilakou T. Quality of life of hemodialysis patients in Greece: associations with socio-economic, anthropometric and nutritional factors. Int J Environ Res Public Health. 2022;19(22):15389. doi:10.3390/ijerph192215389
19. Ku E, Del Vecchio L, Eckardt KU, et al. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;104(4):655-680. doi:10.1016/j.kint.2023.05.009
20. Collister D, Komenda P, Hiebert B, et al. The effect of erythropoieitin- stimulating agents on health-related quality of life in anemia of chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2016;164(7):472-478. doi:10.7326/M15-1839
21. Staibano P, Perelman I, Lombardi J, et al. Patient-centred outcomes in anaemia and renal disease: a systematic review. Kidney Dis (Basel). 2020;6(2):74-84. doi:10.1159/000502208
22. Pretto CR, Winkelmann ER, Hildebrandt LM, Barbosa DA, Colet CF, Stumm EMF. Quality of life of chronic kidney patients on hemodialysis and related factors. Rev Lat Am Enfermagem. 2020;28:e3327. doi:10.1590/ 1518-8345.3641.3327
23. Jalal SM, Beth MRM, Bo Khamseen ZM. Impact of hospitalzation on the quality of life of patients with chronic kidney disease in Saudi Arabia. Int J Environ Res Public Health. 2022;19(15):971. doi:10.3390/ijerph1915918
24. Jesus NM, Souza GF, Mendes-Rodrigues C, Almeida Neto OP, Rodrigues DDM, Cunha CM. Quality of life of individuals with chronic kidney disease on dialysis. J Bras Nefrol. 2019;41(3):364-374. doi:10.1590/2175-8239-JBN-2018-0152
25. Busa I, Ordóñez-Mena JM, Yang Y, et al. Quality of life in older adults with chronic kidney disease and transient changes in renal function: findings from the Oxford Renal cohort. PLoS One. 2022;17(10):e0275572. doi:10.1371/journal.pone.0275572
1. Evans M, Lewis RD, Morgan AR, et al. A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther. 2022;39(1):33-43. doi:10.1007/s12325-021-01927-z
2. https://www.aa.com.tr/tr/saglik/turk-nefroloji-dernegi-bobrek-hastaliklarina-ve-yayginligina-dikkati-cekti/3163411. (Accessed on 24. 09.2024).
3. Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: beyond erythropoietin. Adv Ther. 2021;38(1):52-75. doi: 10.1007/s12325-020-01524-6
4. Pramod S, Goldfarb DS. Challenging patient phenotypes in the management of anaemia of chronic kidney disease. Int J Clin Pract. 2021;75(11):e14681. doi:10.1111/ijcp.14681
5. Van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data. BMC Nephrol. 2020;21(1):88. doi:10.1186/s12882-020-01746-4
6. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 2019;142(1):44-50. doi:10.1159/ 000496492
7. Al-Jabi SW, Rajabi NS, Koni AA, Zyoud SH. A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life. BMC Nephrol. 2023;24(1):197. doi:10. 1186/s12882-023-03254-7
8. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. doi:10.1161/CIR.0000000000000678
9. KDIGO clinical practice guideline for anemia in chronic kidney disease. https://kdigo.org/2023/ on 21.03.2025).
10. Turgeon ML. Cinical Hematology Theory&Procedures. Fifth edition. 2012. Wolters Kluwer, Lippincott Williams&Wilkins. Chapter 10. Iron deficiency Anemia and Anemia of Chronic Inflammation. pp.173-176.
11. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023. doi:10.1056/NEJMra041809
12. Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. 1995; Boston: The Health Institute, New England Medical Center.
13. Soylu C, Bahtım K. Reliability and Validity of the Turkish Version of SF-12 Health Survey. SF-12 Yaşam Kalitesi Ölçeği’nin türkçe formunun güvenirlik ve geçerlilik çalışması. Turk Psikiyatri Derg. 2022;33(2):108-117. doi:10.5080/u25700
14. Doan KVD, Nguyen HTM, Nguyen NTH, Dang KC, Yang SH, Duong TV. Associations of socio-demographic, clinical and biochemical parameters with healthcare cost, health- and renal-related quality of life in hemodialysis patients: a clinical observational study. Int J Environ Res Public Health. 2020;17(18):6552. doi:10.3390/ijerph17186552
15. Mahato SKS, Apidechkul T, Sriwongpan P, et al. Factors associated with quality of life among chronic kidney disease patients in Nepal: a cross-sectional study. Health Qual Life Outcomes. 2020;18(1):207. doi:10.1186/s12955-020-01458-1
16. Chen JY, Wan EYF, Choi EPH, et al. The health-related quality of life of Chinese Patients on hemodialysis and peritoneal dialysis. Patient. 2017; 10(6):799-808. doi:10.1007/s40271-017-0256-6
17. Molsted S, Wendelboe S, Flege MM, Eidemak I. The impact of marital and socioeconomic status on quality of life and physical activity in patients with chronic kidney disease. Int Urol Nephrol. 2021;53(12):2577-2582. doi:10.1007/s11255-021-02826-6
18. Floria I, Kontele I, Grammatikopoulou MG, Sergentanis TN, Vassilakou T. Quality of life of hemodialysis patients in Greece: associations with socio-economic, anthropometric and nutritional factors. Int J Environ Res Public Health. 2022;19(22):15389. doi:10.3390/ijerph192215389
19. Ku E, Del Vecchio L, Eckardt KU, et al. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;104(4):655-680. doi:10.1016/j.kint.2023.05.009
20. Collister D, Komenda P, Hiebert B, et al. The effect of erythropoieitin- stimulating agents on health-related quality of life in anemia of chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2016;164(7):472-478. doi:10.7326/M15-1839
21. Staibano P, Perelman I, Lombardi J, et al. Patient-centred outcomes in anaemia and renal disease: a systematic review. Kidney Dis (Basel). 2020;6(2):74-84. doi:10.1159/000502208
22. Pretto CR, Winkelmann ER, Hildebrandt LM, Barbosa DA, Colet CF, Stumm EMF. Quality of life of chronic kidney patients on hemodialysis and related factors. Rev Lat Am Enfermagem. 2020;28:e3327. doi:10.1590/ 1518-8345.3641.3327
23. Jalal SM, Beth MRM, Bo Khamseen ZM. Impact of hospitalzation on the quality of life of patients with chronic kidney disease in Saudi Arabia. Int J Environ Res Public Health. 2022;19(15):971. doi:10.3390/ijerph1915918
24. Jesus NM, Souza GF, Mendes-Rodrigues C, Almeida Neto OP, Rodrigues DDM, Cunha CM. Quality of life of individuals with chronic kidney disease on dialysis. J Bras Nefrol. 2019;41(3):364-374. doi:10.1590/2175-8239-JBN-2018-0152
25. Busa I, Ordóñez-Mena JM, Yang Y, et al. Quality of life in older adults with chronic kidney disease and transient changes in renal function: findings from the Oxford Renal cohort. PLoS One. 2022;17(10):e0275572. doi:10.1371/journal.pone.0275572
1. Evans M, Lewis RD, Morgan AR, et al. A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther. 2022;39(1):33-43. doi:10.1007/s12325-021-01927-z
2. https://www.aa.com.tr/tr/saglik/turk-nefroloji-dernegi-bobrek-hastaliklarina-ve-yayginligina-dikkati-cekti/3163411. (Accessed on 24. 09.2024).
3. Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: beyond erythropoietin. Adv Ther. 2021;38(1):52-75. doi: 10.1007/s12325-020-01524-6
4. Pramod S, Goldfarb DS. Challenging patient phenotypes in the management of anaemia of chronic kidney disease. Int J Clin Pract. 2021;75(11):e14681. doi:10.1111/ijcp.14681
5. Van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data. BMC Nephrol. 2020;21(1):88. doi:10.1186/s12882-020-01746-4
6. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 2019;142(1):44-50. doi:10.1159/ 000496492
7. Al-Jabi SW, Rajabi NS, Koni AA, Zyoud SH. A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life. BMC Nephrol. 2023;24(1):197. doi:10. 1186/s12882-023-03254-7
8. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. doi:10.1161/CIR.0000000000000678
9. KDIGO clinical practice guideline for anemia in chronic kidney disease. https://kdigo.org/2023/ on 21.03.2025).
10. Turgeon ML. Cinical Hematology Theory&Procedures. Fifth edition. 2012. Wolters Kluwer, Lippincott Williams&Wilkins. Chapter 10. Iron deficiency Anemia and Anemia of Chronic Inflammation. pp.173-176.
11. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023. doi:10.1056/NEJMra041809
12. Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. 1995; Boston: The Health Institute, New England Medical Center.
13. Soylu C, Bahtım K. Reliability and Validity of the Turkish Version of SF-12 Health Survey. SF-12 Yaşam Kalitesi Ölçeği’nin türkçe formunun güvenirlik ve geçerlilik çalışması. Turk Psikiyatri Derg. 2022;33(2):108-117. doi:10.5080/u25700
14. Doan KVD, Nguyen HTM, Nguyen NTH, Dang KC, Yang SH, Duong TV. Associations of socio-demographic, clinical and biochemical parameters with healthcare cost, health- and renal-related quality of life in hemodialysis patients: a clinical observational study. Int J Environ Res Public Health. 2020;17(18):6552. doi:10.3390/ijerph17186552
15. Mahato SKS, Apidechkul T, Sriwongpan P, et al. Factors associated with quality of life among chronic kidney disease patients in Nepal: a cross-sectional study. Health Qual Life Outcomes. 2020;18(1):207. doi:10.1186/s12955-020-01458-1
16. Chen JY, Wan EYF, Choi EPH, et al. The health-related quality of life of Chinese Patients on hemodialysis and peritoneal dialysis. Patient. 2017; 10(6):799-808. doi:10.1007/s40271-017-0256-6
17. Molsted S, Wendelboe S, Flege MM, Eidemak I. The impact of marital and socioeconomic status on quality of life and physical activity in patients with chronic kidney disease. Int Urol Nephrol. 2021;53(12):2577-2582. doi:10.1007/s11255-021-02826-6
18. Floria I, Kontele I, Grammatikopoulou MG, Sergentanis TN, Vassilakou T. Quality of life of hemodialysis patients in Greece: associations with socio-economic, anthropometric and nutritional factors. Int J Environ Res Public Health. 2022;19(22):15389. doi:10.3390/ijerph192215389
19. Ku E, Del Vecchio L, Eckardt KU, et al. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;104(4):655-680. doi:10.1016/j.kint.2023.05.009
20. Collister D, Komenda P, Hiebert B, et al. The effect of erythropoieitin- stimulating agents on health-related quality of life in anemia of chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2016;164(7):472-478. doi:10.7326/M15-1839
21. Staibano P, Perelman I, Lombardi J, et al. Patient-centred outcomes in anaemia and renal disease: a systematic review. Kidney Dis (Basel). 2020;6(2):74-84. doi:10.1159/000502208
22. Pretto CR, Winkelmann ER, Hildebrandt LM, Barbosa DA, Colet CF, Stumm EMF. Quality of life of chronic kidney patients on hemodialysis and related factors. Rev Lat Am Enfermagem. 2020;28:e3327. doi:10.1590/ 1518-8345.3641.3327
23. Jalal SM, Beth MRM, Bo Khamseen ZM. Impact of hospitalzation on the quality of life of patients with chronic kidney disease in Saudi Arabia. Int J Environ Res Public Health. 2022;19(15):971. doi:10.3390/ijerph1915918
24. Jesus NM, Souza GF, Mendes-Rodrigues C, Almeida Neto OP, Rodrigues DDM, Cunha CM. Quality of life of individuals with chronic kidney disease on dialysis. J Bras Nefrol. 2019;41(3):364-374. doi:10.1590/2175-8239-JBN-2018-0152
25. Busa I, Ordóñez-Mena JM, Yang Y, et al. Quality of life in older adults with chronic kidney disease and transient changes in renal function: findings from the Oxford Renal cohort. PLoS One. 2022;17(10):e0275572. doi:10.1371/journal.pone.0275572